• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用荧光原位杂交技术检测96例胶质瘤中p16、RB、CDK4和p53基因的缺失与扩增情况。

Detection of p16, RB, CDK4, and p53 gene deletion and amplification by fluorescence in situ hybridization in 96 gliomas.

作者信息

Perry A, Anderl K, Borell T J, Kimmel D W, Wang C H, O'Fallon J R, Feuerstein B G, Scheithauer B W, Jenkins R B

机构信息

Division of Neuropathology, Washington University, St Louis, Missouri, USA.

出版信息

Am J Clin Pathol. 1999 Dec;112(6):801-9. doi: 10.1093/ajcp/112.6.801.

DOI:10.1093/ajcp/112.6.801
PMID:10587703
Abstract

Inactivation of the p53 gene is a common early event of astrocytoma tumorigenesis. Alternatively, since the p16, retinoblastoma (RB), and CDK4 genes have been implicated in malignant progression, detection of losses or amplifications of these genes in gliomas could be diagnostically, prognostically, and therapeutically important. We obtained smear preparations from 96 diffuse gliomas and 10 nonneoplastic specimens. Dual-color fluorescence in situ hybridizations using paired probes for CEN9/p16, CEN8/RB, CEN17/p53, and CEN12/CDK4 were performed and revealed expected frequencies of abnormalities, except for p53 losses, which were low (7%). The latter supports the concept that p53 inactivation usually occurs by mitotic recombination. Detected abnormalities of the p16/RB/CDK4 pathway were highly associated with astrocytic differentiation and were univariately associated with decreased patient survival. However, only patient age and histologic classification retained statistical significance on multivariate analysis. We conclude that in diffuse gliomas, p16/RB/CDK4 abnormalities are markers of astrocytic phenotype. Thus, their detection by fluorescence in situ hybridization may have diagnostic usefulness in cases with equivocal morphologic features. Although our numbers are small, we find no additional prognostic significance to these genetic abnormalities one age, grade, and oligodendroglial histology are taken into account.

摘要

p53基因失活是星形细胞瘤发生过程中常见的早期事件。另外,由于p16、视网膜母细胞瘤(RB)和CDK4基因与恶性进展有关,检测这些基因在胶质瘤中的缺失或扩增在诊断、预后及治疗方面可能具有重要意义。我们从96例弥漫性胶质瘤和10例非肿瘤标本中获取涂片标本。使用针对CEN9/p16、CEN8/RB、CEN17/p53和CEN12/CDK4的配对探针进行双色荧光原位杂交,结果显示除p53缺失频率较低(7%)外,其他异常频率符合预期。后者支持p53失活通常通过有丝分裂重组发生的观点。检测到的p16/RB/CDK4通路异常与星形细胞分化高度相关,单因素分析显示与患者生存率降低相关。然而,多因素分析中只有患者年龄和组织学分类具有统计学意义。我们得出结论,在弥漫性胶质瘤中,p16/RB/CDK4异常是星形细胞表型的标志物。因此,在形态学特征不明确的病例中,通过荧光原位杂交检测这些异常可能具有诊断价值。尽管我们的样本量较小,但在考虑年龄、分级和少突胶质细胞组织学的情况下,我们发现这些基因异常并无额外的预后意义。

相似文献

1
Detection of p16, RB, CDK4, and p53 gene deletion and amplification by fluorescence in situ hybridization in 96 gliomas.采用荧光原位杂交技术检测96例胶质瘤中p16、RB、CDK4和p53基因的缺失与扩增情况。
Am J Clin Pathol. 1999 Dec;112(6):801-9. doi: 10.1093/ajcp/112.6.801.
2
Detection of p16 gene deletions in gliomas: a comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR.胶质瘤中p16基因缺失的检测:荧光原位杂交(FISH)与定量PCR的比较
J Neuropathol Exp Neurol. 1997 Sep;56(9):999-1008. doi: 10.1097/00005072-199709000-00005.
3
CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.CDKN2A基因缺失和p16表达缺失发生在缺乏RB改变的骨肉瘤中。
Am J Pathol. 1998 Jul;153(1):159-63. doi: 10.1016/S0002-9440(10)65556-3.
4
Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma.家族性胶质瘤中生殖系PTEN、p53、p16(INK4A)/p14(ARF)和CDK4改变的研究。
Am J Med Genet. 2000 May 15;92(2):136-41. doi: 10.1002/(sici)1096-8628(20000515)92:2<136::aid-ajmg11>3.0.co;2-s.
5
Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas.单一 CDKN2A 网络成分的同时异常和高 Rb 磷酸化状态可以区分原发性皮肤 B 细胞淋巴瘤的亚群。
Exp Dermatol. 2011 Apr;20(4):331-5. doi: 10.1111/j.1600-0625.2010.01226.x.
6
Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.胶质母细胞瘤中p16、细胞周期蛋白依赖性激酶4(cdk4)和视网膜母细胞瘤蛋白(pRb)免疫组织化学的分子遗传学关联
J Neuropathol Exp Neurol. 1998 Feb;57(2):122-30. doi: 10.1097/00005072-199802000-00003.
7
Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.胶质瘤中MTS1/p16和MTS2/p15基因的纯合缺失以及CDK4基因的扩增。
Oncogene. 1995 Nov 16;11(10):2145-9.
8
Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivo.细胞周期蛋白依赖性激酶4(CDK4)在星形胶质细胞中的特异性表达不足以引发肿瘤形成,但与p53杂合性协同作用,为星形胶质细胞在体内提供生长优势。
Oncogene. 2002 Feb 21;21(9):1325-34. doi: 10.1038/sj.onc.1205206.
9
Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.人星形细胞瘤中视网膜母细胞瘤、p53、p16(CDKN2)和p15基因的改变。
Cancer. 1996 Jul 15;78(2):287-93. doi: 10.1002/(SICI)1097-0142(19960715)78:2<287::AID-CNCR15>3.0.CO;2-S.
10
Genetic profile of gliosarcomas.胶质肉瘤的基因图谱。
Am J Pathol. 2000 Feb;156(2):425-32. doi: 10.1016/S0002-9440(10)64746-3.

引用本文的文献

1
Homozygous CDKN2A/B deletions in low- and high-grade glioma: a meta-analysis of individual patient data and predictive values of p16 immunohistochemistry testing.同源性缺失 CDKN2A/B 在低级别和高级别胶质瘤中的作用:一项个体患者数据分析和 p16 免疫组化检测预测价值的荟萃分析。
Acta Neuropathol Commun. 2024 Nov 26;12(1):180. doi: 10.1186/s40478-024-01889-7.
2
CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas.CDKN2A/B突变和等位基因特异性改变可对异柠檬酸脱氢酶(IDH)突变型星形细胞瘤的生存结果进行分层。
Acta Neuropathol. 2023 Dec;146(6):845-847. doi: 10.1007/s00401-023-02639-0. Epub 2023 Oct 13.
3
Molecular alterations of low-grade gliomas in young patients: Strategies and platforms for routine evaluation.
年轻患者低级别胶质瘤的分子改变:常规评估的策略与平台
Neurooncol Pract. 2021 Aug 23;8(6):652-661. doi: 10.1093/nop/npab053. eCollection 2021 Dec.
4
Oligodendroglioma: A Review of Management and Pathways.少突胶质细胞瘤:治疗与途径综述
Front Mol Neurosci. 2021 Oct 5;14:722396. doi: 10.3389/fnmol.2021.722396. eCollection 2021.
5
Pediatric low-grade glioma in the era of molecular diagnostics.儿童低级别胶质瘤的分子诊断时代。
Acta Neuropathol Commun. 2020 Mar 12;8(1):30. doi: 10.1186/s40478-020-00902-z.
6
CDK4 in lung, and head and neck cancers in old age: evaluation as a biomarker.老年肺癌及头颈癌中的细胞周期蛋白依赖性激酶4(CDK4):作为生物标志物的评估
Clin Transl Oncol. 2017 May;19(5):571-578. doi: 10.1007/s12094-016-1565-2. Epub 2016 Nov 4.
7
CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas.在低级别(世界卫生组织II - III级)星形细胞瘤中,CDKN2A缺失与总生存期缩短相关。
J Neuropathol Exp Neurol. 2015 May;74(5):442-52. doi: 10.1097/NEN.0000000000000188.
8
Cell Cycle Regulating Kinase Cdk4 as a Potential Target for Tumor Cell Treatment and Tumor Imaging.细胞周期调控激酶 CDK4 作为肿瘤细胞治疗和肿瘤成像的潜在靶点。
J Oncol. 2009;2009:106378. doi: 10.1155/2009/106378. Epub 2009 Jun 17.
9
Ectopic low-grade adrenocortical carcinoma in the spinal region: immunohistochemical and molecular cytogenetic study of a pediatric case.脊髓区域异位低级别肾上腺皮质癌:一例儿科病例的免疫组织化学和分子细胞遗传学研究
Am J Surg Pathol. 2009 Jan;33(1):142-8. doi: 10.1097/PAS.0b013e318180deda.
10
Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.利用放射治疗肿瘤学组试验的组织微阵列,通过荧光原位杂交分析1p、19q、9p和10q作为高级别星形细胞瘤的预后标志物。
Neuro Oncol. 2004 Apr;6(2):96-103. doi: 10.1215/s1152851703000231.